Factors predicting nodal metastasis in endometrial cancer

Archives of Gynecology and Obstetrics

Volumn 290, Issue 6, 2014, Pages 1187-1193

  Gilani, Syed ^a   Anderson, Ian ^a   Fathallah, Lamia ^a   Mazzara, Paul ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Depth of myometrial invasion; Endometrial cancer; Lymph node metastasis; Lymph vascular invasion; Prognosis

Indexed keywords

ADULT; AGED; CANCER STAGING; CARCINOMA; ENDOMETRIAL NEOPLASMS; EVALUATION STUDY; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PELVIS; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; TUMOR INVASION; UTERINE NEOPLASMS;

ADULT; AGED; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PELVIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 84928619104     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3330-5     Document Type: Article

References (27)

1. Todo Y, Suzuki Y, Azuma M, Hatanaka Y, Konno Y, Watari H, Kato H, Matsuno Y, Yamashiro K, Sakuragi N (2012) Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report. Gynecol Oncol 127:532–537
2. Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, Sause WT (2013) Survival analysis of endometrial cancer patients with positive lymph nodes. Int J Gynecol Cancer 23:861–868
3. Yokoyama Y, Maruyama H, Sato S, Saito Y (1997) Indispensability of pelvic and para-aortic lymphadenectomy in endometrial cancers. Gynecol Oncol 64:411–417
4. Akbayir O, Corbacioglu A, Goksedef BP, Numanoglu C, Akca A, Guraslan H, Bakir LV, Cetin A (2012) The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol 125:400–403
5. Garg G, Morris RT, Solomon L, Toy EP, Kruger M, Clary K, Munkarah A, Wright JD (2011) Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecol Oncol 123:208–213
6. Kim HS, Song YS (2009) International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol 20:135–136
7. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL, Abu-Rustum NR (2008) The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18:269–273
8. Kondalsamy-Chennakesavan S, van Vugt S, Sanday K, Nicklin J, Land R, Perrin L, Crandon A, Obermair A (2010) Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int J Gynecol Cancer 20:1217–1221
9. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40:55–65
10. Yasunaga M, Yamasaki F, Tokunaga O, Iwasaka T (2003) Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis. Int J Gynecol Pathol 22:341–346
11. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18
12. Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K (2003) Low risk endometrial cancer: a study of pelvic lymph node metastasis. Int J Gynecol Cancer 13:38–41
13. Vaizoglu F, Yuce K, Salman MC, Basaran D, Calis P, Ozgul N, Usubutun A (2013) Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Arch Gynecol Obstet 288:1391–1397
14. Kwon JS, Qiu F, Saskin R, Carey MS (2009) Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet Gynecol 114:736–743
15. Kamura T, Yahata H, Shigematsu T, Ogawa S, Amada S, Kaku T, Nakano H (1999) Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol 72:387–391
16. Zhang C, Wang C, Feng W (2012) Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer 22:1373–1377
17. Schink JC, Lurain JR, Wallemark CB, Chmiel JS (1987) Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol 70:216–219
18. Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, Goff B (2005) Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 99:564–570
19. Schink JC, Rademaker AW, Miller DS, Lurain JR (1991) Tumor size in endometrial cancer. Cancer 67:2791–2794
20. Mikuta JJ (1993) International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 71:1460–1463
21. Shepherd JH (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96:889–892
22. Tebeu PM, Popowski GY, Verkooijen HM, Casals J, Lüdicke F, Zeciri G, Usel M, Bouchardy C, Major AL (2003) Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Br J Cancer 89:2023–2026
23. Grimshaw RN, Tupper WC, Fraser RC, Tompkins MG, Jeffrey JF (1990) Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 36:97–100
24. Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, Ohmi K, Sasajima Y, Matsuno Y (2003) Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 88:245–250
25. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104
26. Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR, Alektiar KM (2013) Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol 130:49–53
27. Garg G, Gao F, Wright JD, Hagemann AR, Zighelboim I, Mutch DG, Powell MA (2013) The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer. Int J Gynecol Cancer 23:90–97